ROYCE & ASSOCIATES LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$339,864
-40.6%
202,3000.0%0.00%
-50.0%
Q2 2023$572,509
-42.4%
202,3000.0%0.01%
-40.0%
Q1 2023$993,293
-54.3%
202,3000.0%0.01%
-56.5%
Q4 2022$2,172,702
+8.4%
202,300
-5.5%
0.02%0.0%
Q3 2022$2,005,000
+118.4%
214,157
+113.0%
0.02%
+155.6%
Q2 2022$918,000
-32.3%
100,548
-9.9%
0.01%
-25.0%
Q1 2022$1,356,000
+742.2%
111,592
+744.0%
0.01%
+1100.0%
Q4 2021$161,000
-31.2%
13,222
-12.7%
0.00%
-50.0%
Q3 2021$234,00015,1440.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders